Baker Bros. Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,225,255
| Closed | -$25.8M | – | 111 |
|
|
2022
Q4 | $25.8M | Sell |
1,225,255
-2,074,754
| -63% | -$43.6M | 0.15% | 34 |
|
|
2022
Q3 | $81.3M | Hold |
3,300,009
| – | – | 0.53% | 17 |
|
|
2022
Q2 | $80M | Hold |
3,300,009
| – | – | 0.45% | 17 |
|
|
2022
Q1 | $85M | Buy |
3,300,009
+630,955
| +24% | +$16.3M | 0.49% | 16 |
|
|
2021
Q4 | $82.8M | Buy |
2,669,054
+629,282
| +31% | +$19.5M | 0.4% | 22 |
|
|
2021
Q3 | $49.5M | Buy |
2,039,772
+1,852,857
| +991% | +$44.9M | 0.22% | 38 |
|
|
2021
Q2 | $2.73M | Hold |
186,915
| – | – | 0.01% | 108 |
|
|
2021
Q1 | $4.67M | Buy |
+186,915
| New | +$4.67M | 0.02% | 98 |
|
|
2014
Q2 | – | Sell |
-197,178
| Closed | -$4.19M | – | 109 |
|
|
2014
Q1 | $4.19M | Buy |
+197,178
| New | +$4.19M | 0.05% | 79 |
|